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A B S T R A C T
Background
Breast milk alone, given at standard recommended volumes (150 to 180 mL/kg/d), is not adequate to meet the protein, energy, and
other nutrient requirements of growing preterm or low birth weight infants. One strategy that may be used to address these potential
nutrient deﬁcits is to give infants enteral feeds in excess of 200 mL/kg/d (’high-volume’ feeds). This approach may increase nutrient
uptake and growth rates, but concerns include that high-volume enteral feeds may cause feed intolerance, gastro-oesophageal reﬂux,
aspiration pneumonia, necrotising enterocolitis, or complications related to ﬂuid overload, including patent ductus arteriosus and
bronchopulmonary dysplasia.
Objectives
To assess the effect on growth and safety of feeding preterm or low birth weight infants with high (> 200 mL/kg/d) versus standard (≤
200 mL/kg/d) volume of enteral feeds. Infants in intervention and control groups should have received the same type of milk (breast
milk, formula, or both), the same fortiﬁcation or micronutrient supplements, and the same enteral feeding regimen (bolus, continuous)
and rate of feed volume advancement.
To conduct subgroup analyses based on type of milk (breast milk vs formula), gestational age or birth weight category of included
infants (very preterm or VLBW vs preterm or LBW), presence of intrauterine growth restriction (using birth weight relative to the
reference population as a surrogate), and income level of the country in which the trial was conducted (low or middle income vs high
income) (see ’Subgroup analysis and investigation of heterogeneity’).
Search methods
We used the Cochrane Neonatal standard search strategy, which included searches of the Cochrane Central Register of Controlled Trials
(CENTRAL; 2017, Issue 2) in the Cochrane Library; MEDLINE (1946 to November 2016); Embase (1974 to November 2016); and
the Cumulative Index to Nursing and AlliedHealth Literature (CINAHL; 1982 to November 2016), as well as conference proceedings,
previous reviews, and trial registries.
Selection criteria
Randomised and quasi-randomised controlled trials that compared high-volume versus standard-volume enteral feeds for preterm or
low birth weight infants.
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Data collection and analysis
Two review authors assessed trial eligibility and risk of bias and independently extracted data.We analysed treatment effects in individual
trials and reported the risk ratio and risk difference for dichotomous data, and the mean difference for continuous data, with respective
95% conﬁdence intervals. . We assessed the quality of evidence at the outcome level via the GRADE approach.
Main results
We found one eligible trial that included 64 infants. This trial was not blinded. Analysis showed a higher rate of weight gain in the
high-volume feeds group: mean difference 6.20 g/kg/d (95% conﬁdence interval 2.71 to 9.69). There was no increase in the risk of feed
intolerance or necrotising enterocolitis with high-volume feeds, but 95% conﬁdence intervals around these estimates were wide. We
assessed the quality of evidence for these outcomes as ’low’ or ’very low’ because of imprecision of the estimates of effect and concern
about risk of bias due to lack of blinding in the included trial. Trial authors provided no data on other outcomes, including gastro-
oesophageal reﬂux, aspiration pneumonia, necrotising enterocolitis, patent ductus arteriosus, bronchopulmonary dysplasia, or long-
term growth and neurodevelopment.
Authors’ conclusions
We found only very limited data from one small unblinded trial on the effects of high-volume feeds on important outcomes for preterm
or low birth weight infants. The quality of evidence is low to very low. Hence, available evidence is insufﬁcient to support or refute
high-volume enteral feeds in preterm or low birth weight infants. A large, pragmatic randomised controlled trial is needed to provide
data of sufﬁcient quality and precision to inform policy and practice.
P L A I N L A N G U A G E S U M M A R Y
High versus standard volumes of feeds for preterm or low birth weight infants
Review question
Does giving preterm or low birth weight infants more milk than is usually given promote growth without causing feeding problems?
Background
Infants born very early (preterm) or very small (low birth weight) need extra nutrients for growth compared to bigger or more mature
infants. One way to deliver extra nutrition is to give infants more milk than usual (“high-volume feeds”), typically more than 200
mL per kilogram per day. Although giving high volumes of milk to preterm or low birth weight infants might increase growth rates,
concerns include that infants may not tolerate high-volume feeds and may experience side effects including severe bowel problems. We
have looked for evidence from clinical trials that assessed whether high-volume feeds are beneﬁcial or harmful for preterm or low birth
weight infants.
Study characteristics
Through literature searches up-to-date until Novebember 2016, we found only one small randomised controlled trial (with 64 very
low birth weight infant participants) that addressed this question.
Key results
Very low birth weight infants who receive more milk than standard volumes gain weight more quickly during their hospital stay. We
found no evidence suggesting that giving infants high volumes of milk causes feeding or gut problems, but this ﬁnding is not certain.
Conclusions
Available evidence is insufﬁcient to support or refute the use of high-volume feeds in preterm or low birth weight infants. High-volume
feeds might increase the rate of weight gain, but more trials are needed to conﬁrm this ﬁnding and to examine whether high-volume
feeds cause any problems for preterm or low birth weight infants.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
High-volume feeds vs standard-volume feeds for preterm or low birth weight infants
Patient or population: preterm or low birth weight infants
Setting: neonatal care facilit ies
Intervention: high-volume feeds
Comparison: standard-volume feeds
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Risk with standard-volume
feeds
Risk with high-volume
feeds
Weight gain (g/ kg/ d) Mean weight gain was 18.7
g/ kg/ d
Mean weight gain was 6.2
g/ kg/ d higher
(2.71 higher to 9.69 higher)
- 61
(1 RCT)
⊕⊕©©
LOWa,b
Feed intolerance Study populat ion RR 1.81
(0.89 to 3.67)
61
(1 RCT)
⊕⊕©©
LOWa,b
258 per 1000 467 per 1000
(230 to 947)
Necrot ising enterocolit is Study populat ion RR 1.03
(0.07 to 15.78)
61
(1 RCT)
⊕©©©
VERY LOWa,c
32 per 1000 33 per 1000
(2 to 509)
*Risk in the intervention group (and its 95% CI) is based on assumed risk in the comparison group and relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; RCT: randomised controlled trial; RR: risk rat io
aDowngraded for risk of bias (lack of blinding).
bDowngraded for imprecision.
cDowngraded (by 2) for serious imprecision.
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B A C K G R O U N D
Description of the condition
The optimal growth rate of infants born preterm or with low
birth weight (LBW) is not known (Higgins 2012). Consensus
guidelines suggest that caregivers should aim to achieve a post-
natal growth rate similar to the gestation-equivalent foetal in-
trauterine growth rate (Agostoni 2010). Many preterm or LBW
infants, especially those born very preterm or at very low birth
weight (VLBW), do not achieve these rates of growth and are
growth restricted at the time of hospital discharge (Ehrenkranz
1999; Steward 2002; Clark 2003; Cooke 2004; Sakurai 2008;
Shan 2009; Lima 2014; Horbar 2015; Stevens 2016). Growth
deﬁcits can persist through childhood and adolescence and into
adulthood (Dusick 2003; Hack 2003; Brandt 2005; Euser 2008;
Stein 2013). Slow postnatal growth is associated with neurode-
velopmental impairment and with poorer cognitive and scholastic
outcomes (Brandt 2003; Franz 2009; Neubauer 2013; Leppanen
2014). Furthermore, concerns include that nutritional deﬁciency
and growth restriction during infancy may have adverse effects
on long-term metabolic and cardiovascular health (Higgins 2012;
Embleton 2013; Lapillonne 2013).
Description of the intervention
Human breast milk is the recommended form of enteral nutrition
for newborn infants for at least the ﬁrst six months of postnatal life
(Johnston 2012). However, breast milk alone, given at volumes
that meet the nutritional needs of term infants, may not meet
the higher nutritional requirements of growing preterm or LBW
infants (Embleton 2007). International consensus guidelines state
that ’standard’ volumes (about 150 to 180mL/kg/d) of breast milk
do not provide the recommended amount of energy (110 to 135
kCal/kg/d) or protein (3.5 to 4.5 g/kg/d) to meet the metabolic
needs of very preterm or VLBW infants (Table 1) (CPS 1995; AAP
2004; Agostoni 2010).
In neonatal care facilities in high-income countries, the strategy
most commonly employed to address these potential nutrient
deﬁcits is to supplement breast milk with extra nutrients, usu-
ally in the form of a commercially available powder or liquid
’multi-nutrient fortiﬁer’ extracted from cow’s milk (Uhing 2009;
Klingenberg 2012; Cormack 2013; Dutta 2015). Multi-nutrient
fortiﬁcation may be especially important for infants who receive
donated (donor expressed) breast milk, which typically contains
lower levels of energy and protein than breast milk expressed by
themother (Arslanoglu 2013). A Cochrane Review of randomised
controlled trials provides evidence that feeding preterm infants
with multi-nutrient fortiﬁed breast milk rather than unfortiﬁed
breast milk increases growth rates during the initial hospitalisation
period (Brown 2016). However, commercially available fortiﬁers
are expensive, and their use is less feasible in resource-poor settings
in low- or middle-income countries (Chawla 2008; Kler 2015).
’High-volume’ feeds
An alternative, cheaper way of meeting the recommended daily
intakes of energy, protein, and other nutrients for preterm or LBW
infants is to increase the total volume of enteral feeds (Klingenberg
2012). Feedingpretermor LBWinfantswith daily volumes ofmilk
in excess of 200 mL/kg (’high-volume’ feeds) has been proposed as
a safe and effective growth-enhancement strategy (Valman 1974;
Lewis 1984; Doege 2007). Whereas feeding preterm or LBW in-
fants with unfortiﬁed maternal breast milk at 150 mL/kg/d typ-
ically would provide 100 kCal/kg/d and between 1.8 and 3.0 g/
kg/d of protein (depending on the type of expressed breast milk),
feeding at 200 mL/kg/d could provide 135 kCal/kg/d and be-
tween 2.4 and 4.0 g/kg/d of protein. However, because of con-
cerns about ﬂuid overload and complications such as feed intol-
erance, necrotising enterocolitis (NEC), patent ductus arteriosus
(PDA), bronchopulmonary dysplasia (BPD), and metabolic com-
plications such as hyponatraemia, high-volume enteral feeding has
not become an established practice (Chawla 2008; Sankar 2008;
Bertino 2009; Klingenberg 2012; Raban 2013).
Formula feeding
Standard ’term’ formula, designed to match the composition of
mature breast milk, does not provide the recommended nutri-
ent needs for growing preterm infants. Commercially available
’preterm formula’, enriched with energy (about 80 kCal/100 mL)
and protein (about 2.2 g/100 mL), is commonly used to provide
the extra nutrients required without increasing the volume of feeds
beyond about 150 mL/kg/d to 180 mL/kg/d (Klingenberg 2012;
Tudehope 2013). Nutrient-enriched formula is more expensive,
is not widely available, and is used less often in low- and middle-
income countries (Chawla 2008). Theoretically, the same strategy
as applies to breast milk-fed infants could apply, that is, high-vol-
ume feeding with standard formula as a cheaper and more read-
ily available alternative to standard-volume feeding with nutrient-
enriched preterm formula.
How the intervention might work
Feeding preterm or LBW infants higher volumes of milk (more
than 200 mL/kg/d) may be expected to promote nutrient accre-
tion and faster rates of growth (increase in weight, length, and
head circumference). Higher levels of nutrient intake during this
critical period may be important for optimising long-term growth
and neurodevelopment (Embleton 2013). Potential disadvantages
of high-volume enteral feeding also are known. High volumes of
milk may add to the physiological and metabolic stress of the im-
mature gastrointestinal tract and its blood supply, thus increasing
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risk of NEC. This may result in or worsen gastro-oesophageal re-
ﬂux, increasing risk of apnoea or aspiration. High-volume feeds
may lead to ﬂuid overload and associated complications such as
peripheral or pulmonary oedema, PDA, and BPD. Furthermore,
enteral feeding that is ceased owing to intolerancemay reduce total
nutrient intake over time, thus adversely affecting growth.
Why it is important to do this review
Given the potential of high-volume enteral feeding to increase nu-
trient accretion and growth rates, while improving developmental
outcomes in preterm or LBW infants, as well the potential risks of
this feeding strategy, we undertook a systematic review that would
identify and appraise data from randomised controlled trials, to
provide a synthesis of evidence that could inform practice and re-
search. No systematic review has examined this topic.
O B J E C T I V E S
Toassess the effect on growth and safety of feedingpretermor LBW
infants with high (> 200 mL/kg/d) versus standard (≤ 200 mL/
kg/d) volume of milk. Infants in intervention and control groups
should have received the same type of milk (breast milk, formula,
or both), the same fortiﬁcation ormicronutrient supplements, and
the same enteral feeding regimen (bolus, continuous) and rate of
feed volume advancement.
To conduct subgroup analyses based on type ofmilk (breastmilk vs
formula), gestational age or birth weight category of included in-
fants (very preterm or VLBW vs preterm or LBW), presence of in-
trauterine growth restriction (using birth weight relative to the ref-
erence population as a surrogate), and income level of the country
in which the trial was conducted (low ormiddle income vs high in-
come) (see Subgroup analysis and investigation of heterogeneity).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised and quasi-randomised controlled trials, including
cluster-randomised controlled trials.
Types of participants
Preterm (< 37 weeks’ gestational age) or LBW (< 2500 grams)
infants.
Types of interventions
• Intervention: high-volume enteral feeds: > 200 mL/kg/d
• Control: standard-volume enteral feeds: ≤ 200 mL/kg/d
Infants might have been randomised to the allocated intervention
at any stage up to the time of achieving full enteral feeding volumes.
The prescribed feeding regimen should have been followed until
the infant was able to self-regulate intake.
Types of outcome measures
Primary outcomes
• Rates of weight gain (g/kg/d), linear growth (cm/week), or
head growth (cm/week) during hospital stay and z-scores for
these parameters; proportion of infants who remain below the
10th percentile for the index population up to discharge from
hospital
• Growth measures following discharge from hospital to
latest follow-up
Secondary outcomes
• Neurodevelopmental outcomes assessed after 12 months
post term: neurological evaluations; developmental scores; and
classiﬁcations of disability, including auditory and visual
disability. We will deﬁne neurodevelopmental impairment as the
presence of one or more of the following: non-ambulant cerebral
palsy; developmental quotient greater than two standard
deviations below the population mean; and blindness (visual
acuity < 6/60) or deafness (any hearing impairment requiring, or
unimproved by, ampliﬁcation)
• Number of infants with feed intolerance: vomiting,
excessive gastric residual volumes (deﬁned by investigators), or
abdominal distension that results in reduction or cessation of
enteral feeding
• Number of infants with aspiration pneumonia or
pneumonitis (clinical or radiological evidence of lower
respiratory tract compromise that has been attributed to covert
or evident aspiration of gastric contents)
• Number of infants with gastro-oesophageal reﬂux
diagnosed by (i) clinical features; post-feed (if bolus-fed) apnoea,
desaturation, irritability, or vomiting; or (ii) oesophageal pH
monitoring, multiple intraluminal impedance, or endoscopy
• Frequency of apnoea (no respiratory effort > 20 seconds) or
bradycardia (< 100 beats per minute), or apnoea/bradycardia
necessitating stimulation, oxygen administration increase, or
positive-pressure ventilation (mean number of episodes per day)
• Frequency of episodes of spontaneous fall in oxygen
saturation (SpO ) to 85% or less (mean number of episodes per
day)
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• Number of infants with NEC (modiﬁed Bell stage 2/3;
Walsh 1986)
• Number of infants with BPD (oxygen supplementation at
36 weeks’ postmenstrual age)
• Number of infants with PDA treated pharmacologically or
surgically+++
• All-cause mortality before discharge or up to 44 weeks’
postmenstrual age
• Mean duration of hospital stay (days)
Search methods for identification of studies
We used the standard search strategy of Cochrane Neonatal (
neonatal.cochrane.org/resources-review-authors).
Electronic searches
We searched the Cochrane Central Register of Controlled Trials
(CENTRAL; 2017, Issue 2) in the Cochrane Library; MEDLINE
(1946 to November 2016); Embase (1974 to November 2016);
the Cumulative Index to Nursing and Allied Health Literature
(CINAHL; 1982 to November 2016); and Maternity and Infant
Care (1971 to November 2016). We limited search outputs with
relevant search ﬁlters for clinical trials, as recommended in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011). We did not apply any language restrictions. See Appendix
1 for details of the search terms that we used.
We searched ClinicalTrials.gov, Current Controlled Trials, and
the World Health Organization International Trials Registry and
Platform (www.whoint/ictrp/search/en/) for completed or ongo-
ing trials.
Searching other resources
We examined reference lists in related reviews, included, and ex-
cluded studies. We searched the proceedings of annual meetings
of the Pediatric Academic Societies (1993 to 2016), the European
Society for Paediatric Research (1995 to 2016), the Royal College
of Paediatrics and Child Health (2000 to 2017), and the Perinatal
Society of Australia and New Zealand (2000 to 2016). Trials re-
ported only as abstracts were eligible if sufﬁcient information was
available from the report, or from contact with trial authors, to
fulﬁl inclusion criteria.
Data collection and analysis
We used standard methods of Cochrane Neonatal.
Selection of studies
We screened the title and abstract of all studies identiﬁed by the
above search strategy, and two review authors (TA and WM) in-
dependently assessed the full articles for all potentially relevant
trials. We excluded studies that did not meet all of the inclusion
criteria, and we stated the reason for exclusion. We discussed dis-
agreements until we achieved consensus.
Data extraction and management
Two review authors (TA and WM) extracted data independently
using a data collection form to aid extraction of information on
design, methods, participants, interventions, outcomes, and treat-
ment effects from each included study. We discussed disagree-
ments until we reached consensus. If data from trial reports were
insufﬁcient, we contacted trialists to request further information.
Assessment of risk of bias in included studies
We used criteria and standard methods of Cochrane Neonatal to
assess the methodological quality of included trials. Two review
authors (TA and VA) assessed risk of bias across key domains
(Appendix 2) and resolved disagreements in consultation with a
third review author (WM). We requested additional information
from trial authors to clarify methods and results when necessary.
Measures of treatment effect
We analysed treatment effects in individual trials using Review
Manager 5 and reported risk ratios (RRs) and risk differences
(RDs) for dichotomous data, and mean differences (MDs) for
continuous data, with respective 95% conﬁdence intervals (CIs)
(Review Manager 5). We determined the number needed to treat
for an additional beneﬁcial outcome (NNTB) or an additional
harmful outcome (NNTH) for analyses with a statistically signif-
icant difference in RD.
Unit of analysis issues
The unit on analysis was the participating infant in individual ran-
domised controlled trials (RCTs). For cluster-RCTs, we planned
to undertake analyses at the level of the individual while account-
ing for clustering in the data using methods recommended in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011).
Dealing with missing data
We requested additional data from trialists if information on im-
portant outcomes was missing or was reported unclearly. When
data were still missing, we planned to examine the impact on ef-
fect size estimates in sensitivity analyses using the ’best-worst case
scenario’ technique.
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Assessment of heterogeneity
We planned to examine treatment effects of individual trials and
heterogeneity between trial results by inspecting forest plots. We
planned to calculate the I² statistic for each RR analysis to quantify
inconsistency across studies and to describe the percentage of vari-
ability in effect estimates that may be due to heterogeneity rather
than to sampling error. If we detected moderate or high hetero-
geneity (I² ≥ 50%), we planned to explore possible causes (e.g.
differences in study design, participants, interventions, or com-
pleteness of outcome assessments).
Assessment of reporting biases
If we included more than 10 trials in a meta-analysis, we planned
to examine a funnel plot for asymmetry.
Data synthesis
We planned to use a ﬁxed-effect model for meta-analyses.
Quality of evidence
We assessed the quality of evidence for the main comparison at
the outcome level using the GRADE approach (Appendix 3). Two
review authors (TA and VA) assessed independently the quality
of evidence found for outcomes identiﬁed as critical or important
for clinical decision making. We considered evidence from RCTs
as high quality but downgraded evidence one level for serious (or
two levels for very serious) limitations on the basis of the follow-
ing: design (risk of bias), consistency across studies, directness of
evidence, precision of estimates, and presence of publication bias.
We usedGRADEproGDT to create a ‘Summary of ﬁndings’ (SoF)
table to report the quality of evidence (GRADEproGDT).
Subgroup analysis and investigation of heterogeneity
We planned to undertake these subgroup analyses, when possible.
• Very preterm (< 32 weeks’ gestation) or VLBW (< 1500
grams) infants versus preterm infants born at between 32 and 36
weeks’ gestation or with birth weight 1500 to 2499 grams.
• Breast milk-fed versus formula-fed infants.
• Infants with birth weight below the 10th percentile for the
reference population (’small for gestational age’) versus infants
with birth weight ’appropriate for gestational age’.
• Trials conducted in low- or middle-income versus high-
income countries (data.worldbank.org/about/country-
classiﬁcations).
Sensitivity analysis
Weplanned to undertake sensitivity analyses to determine whether
ﬁndings were affected when only studies using adequate methods
were included (low risk of bias); adequate methods were deﬁned as
adequate randomisation and allocation concealment, blinding of
intervention and measurement, and less than 10% loss to follow-
up.
R E S U L T S
Description of studies
See Characteristics of included studies, Characteristics of excluded
studies, and Characteristics of ongoing studies.
Results of the search
See Figure 1.
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Figure 1. Study flow diagram.
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Included studies
We included one trial (Thomas 2012).
The trial enrolled 64 VLBW infants (Thomas 2012). Both ap-
propriate-for-gestational-age and small-for-gestational-age infants
were eligible to participate. Infants in the intervention arm re-
ceived 300 mL/kg/d, and those in the control arm were given 200
mL/kg/d. Participants were fed with expressed breast milk plus
individual micronutrient supplementation for iron, calcium, and
vitamins. Multi-nutrient fortiﬁers, which supplement calories and
protein, were not used. The primary outcome was daily rate of
weight gain from enrolment until the infant reached 1700 grams
weight. Secondary outcomes were feed intolerance (two episodes
of vomiting or pre-feed gastric aspirates > 50%of previous feed vol-
ume), tachypnoea (respiratory rate > 60 breaths per minute), PDA
(diagnosed clinically or by echocardiograph), NEC (Bell stage 2a
or greater), invasive infection (conﬁrmed by blood culture), and
biochemical abnormalities.
Excluded studies
We excluded four studies (Characteristics of excluded studies).
• We excluded two RCTs (Kuschel 2000; Zecca 2014). One
of these compared 200 mL/kg/d versus 150 mL/kg/d (Kuschel
2000). This study did not meet our eligibility criteria, which
deﬁned any volume up to 200 mL/kg/d as standard-volume
feeds, and volumes > 200 mL/kg/d as high-volume feeds. The
other trial compared 200 mL/kg/d versus 170 mL/kg/d, and
reported rates of feed volume advancement that were different
between intervention and control groups (Zecca 2014).
• Two studies were not RCTs (Valman 1974; Lewis 1984).
One was an observational study of LBW infants fed 250 mL/kg/
d of milk (Lewis 1984). The other was a cohort study comparing
two enteral feed volumes; 180 and 230 mL/kg/d (Valman 1974).
Risk of bias in included studies
See Figure 2.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for the included
study.
Allocation
The included trial used computer-generated random numbers for
sequence generation and sealed opaque envelopes for allocation
concealment (Thomas 2012; personal communication).
Blinding
This trial was unblinded.
Incomplete outcome data
Investigators assessed all participants for primary and secondary
outcomes.
Selective reporting
The study protocol was not published. Researchers reported all
proposed outcomes (personal communication).
Other potential sources of bias
We identiﬁed no other potential source of bias.
Effects of interventions
See: Summary of findings for the main comparison High-
volume feeds vs standard-volume feeds for preterm or low birth
weight infants
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Primary outcomes
Growth during initial hospital stay (Outcome 1.1)
Trialists reported a higher rate of weight gain in the intervention
group (MD 6.2, 95% CI 2.71 to 9.69 g/kg/d; 1 trial, 64 partic-
ipants) (Analysis 1.1; Figure 3). This trial did not report linear
growth and head growth (Thomas 2012).
Figure 3. Forest plot of comparison: 1 High-volume vs standard-volume feeds, outcome: 1.1 Weight gain
(g/kg/d).
Post-hospital discharge growth
Trialists did not report growth after hospital discharge (Thomas
2012).
Secondary outcomes
Neurodevelopmental outcomes
Trialists did not report any neurodevelopmental outcomes (
Thomas 2012).
Feed intolerance (Outcome 1.2)
Trialists did not show a difference in the incidence of feed intol-
erance (RR 1.81, 95% CI 0.89 to 3.67; 1 trial, 64 participants)
(Analysis 1.2; Figure 4) (Thomas 2012).
Figure 4. Forest plot of comparison: 1 High-volume vs standard-volume feeds, outcome: 1.2 Feed
intolerance.
Aspiration pneumonia
Trialists did not report aspiration pneumonia as an outcome (
Thomas 2012).
Gastro-oesophageal reflux
Trialists did not report gastro-oesophageal reﬂux as an outcome
(Thomas 2012).
Frequency of apnoea/bradycardia/desaturation
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Trialists did not report frequency of apnoea/bradycardia/desatu-
ration as an outcome (Thomas 2012).
NEC stage 2/3 (Outcome 1.3)
Trialists did not show a difference in risk of NEC stage 2/3 (RR
1.03, 95% CI 0.07 to 15.78) (Analysis 1.3; Figure 5) (Thomas
2012).
Figure 5. Forest plot of comparison: 1 High-volume vs standard-volume feeds, outcome: 1.3 Necrotising
enterocolitis.
BPD
Trialists did not report BPD as an outcome (Thomas 2012).
PDA
Trialists did not report PDA as an outcome (Thomas 2012).
All-cause mortality before discharge or at 44 weeks
Trialists reported no death in either of the groups (Thomas 2012).
Duration of hospital stay
Trialists did not report duration of hospital stay as an outcome
(Thomas 2012).
Subgroup analyses
• Very preterm or VLBW infants: All participants in the
included trial were VLBW
• Breast milk-fed infants: All participants in the included trial
were breast milk fed.
• Small-for-gestational-age infants: Trialists did not show a
statistically signiﬁcant effect on rate of weight gain in a subgroup
of small-for-gestational-age infants: High volume (n = 10) 22.5
g/kg/d versus standard volume (n = 14) 17.6 g/kg/d. Trialists did
not report standard deviations (SDs) and did not report data for
appropriate-for-gestational-age infants, so a subgroup
comparison was not possible (Thomas 2012).
• Low- or middle-income countries: The only included trial
was conducted in a low- or middle-income country (India).
D I S C U S S I O N
Summary of main results
Only one small randomised controlled trial (RCT) met the in-
clusion criteria for this Cochrane Review (Thomas 2012). This
trial was unblinded but otherwise of good methodological quality.
Analysis showed a higher rate of weight gain in the high-volume
enteral feeds group. An increase in weight gain of 6.2 g/kg/d in the
high-volume feeds group would be clinically signiﬁcant because it
amounts to 43 g/kg/week and 186 g/kg/month. However, owing
to the small sample size (n = 64), data is insufﬁcient to provide
a precise estimate of the effect of high-volume enteral feeds on
risk of necrotising enterocolitis (NEC) and feed intolerance. We
found no data for other outcomes such as linear and head growth,
post-discharge growth, duration of hospital stay, neurodevelop-
mental outcomes, and risk of complications such as patent ductus
arteriosus (PDA), bronchopulmonary dysplasia (BPD), aspiration
pneumonia, or gastro-oesophageal reﬂux.
Overall completeness and applicability of
evidence
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Although the included trial showed that high-volume enteral feeds
increase the rate of weight gain, it is plausible that giving high
volumes could have resulted in greater feed intolerance and inter-
ruption or cessation of enteral feeding that in turn reduced growth
rates. The included trial prespeciﬁed deﬁnitions of feed intolerance
that mandated interrupting or ceasing feed volume advancement -
principally two ore more episodes of vomiting - or detecting a pre-
feed ’gastric residual volume’ that was more than half the volume
of the preceding enteral feed. This trial did not show a statistically
signiﬁcant difference in the incidence of feed intolerance, but the
95% conﬁdence interval (CI) was wide (risk ratio (RR) 1.81, 95%
CI 0.89 to 3.67), with the upper bound consistent with a greater
than three-fold increase in the incidence of feed intolerance. Sim-
ilarly, the estimate of effect on the risk of NEC is imprecise, with
the upper bound of the 95%CI (RR 1.03, 95% CI 0.07 to 15.78)
consistent with a greater than 15-fold increase in the incidence of
NEC.
Most participants in the included trial were stable very preterm
(mean gestational age at birth: 32 weeks) or very low birth weight
(VLBW) (mean birth weight: 1200 g) infants. About two-ﬁfths
of all participants were small for gestational age. Owing to lack
of data, however, subgroup comparisons of appropriate-for-gesta-
tional-age versus small-for-gestational-age infants were not possi-
ble. The fact that risks of feed intolerance and NEC may differ
between these groups of infants may limit the applicability of these
data from a low- or middle-income country, where being small for
gestational age is a major contributor to VLBW, to high-income
countries, where short gestation (with appropriate growth) is the
main cause. It is not clear, furthermore, whether study ﬁndings are
applicable to other subgroups of infants at risk of developing feed
intolerance or NEC, including those with intrauterine growth re-
striction or compromise, as investigators did not assess these risk
factors.
All infants recruited to the included trial were fed with expressed
maternal breast milk. Human milk feeding reduces the risk of feed
intolerance and NEC in preterm infants, and it is unclear whether
this ﬁnding could be applied to infants fed artiﬁcial formulas. Sim-
ilarly, all participants received bolus intragastric feeds at two- to
three-hourly intervals, and it is unclear whether ﬁndings can be
applied to infants who receive continuous infusion of intragastric
feeds, because RCTs have reported conﬂicting ﬁndings about ef-
fects of continuous enteral infusion on feed tolerance and NEC
in very preterm or VLBW infants (Premji 2011).
Quality of the evidence
The quality of the evidence from the only included trial was low
for the primary outcome of weight gain (downgraded for lack of
blinding and imprecision of results). The quality of evidence was
very low for feed intolerance and NEC (downgraded for lack of
blinding and serious imprecision of results).
Although allocation was concealed in the included trial, the in-
tervention was not blinded to caregivers and investigators, and
surveillance bias may have inﬂuenced assessment of some out-
comes, including feed intolerance and NEC. Clinicians’ and care-
givers’ subjective assessments of when to investigate (e.g. examin-
ing the infant’s abdomen for tenderness or distension) or inter-
vene (e.g. interrupting or ceasing enteral feeds) may have been
affected by perceived risks associated with high-volume feeds. The
unblinded design may also have inﬂuenced care practices. For ex-
ample, the perception that high-volume feeds may be more likely
to cause gastro-oesophageal reﬂux may inﬂuence the attitude of
healthcare staff regarding investigation ormanagement of episodes
of apnoea, bradycardia, or oxygen desaturation (linked putatively
to reﬂux).
Potential biases in the review process
We found only one small trial for inclusion in this review. Al-
though we conducted a comprehensive search, including a search
of conference proceedings, we cannot exclude fully the possibil-
ity of publication bias because we do not know whether other
published (but not indexed) or unpublished trials have been con-
ducted.
Agreements and disagreements with other
studies or reviews
We are not aware of other systematic reviews on the use of high-
volume enteral feeds to increase nutrient intake in preterm or low
birth weight infants.
Two of the studies excluded from this review were RCTs involv-
ing preterm infants in neonatal units in high-income countries
(Kuschel 2000; Zecca 2014). Although these trials compared dif-
ferent volumes of enteral feeds, in both the studies the higher vol-
ume was 200 mL/kg/d, which is the upper limit for our a priori
deﬁnition of “standard-volume” feeds.
Consistent with our included trial, both trials showed higher rates
of weight gain among infants fed higher volumes of milk than
among those given standard volumes of milk: weight gain of 16.2
versus 15.7 g/kg/d until discharge in one study, and discharge
weight z-score of -2.04 versus -2.31 in the other study (Kuschel
2000; Thomas 2012; Zecca 2014). However, higher-volume feeds
did not result in greater length andhead circumference at discharge
in both studies. The other beneﬁt of higher-volume feeds was
shorter duration of hospital stay (Zecca 2014). Although one study
showed higher rates of ﬂuid retention in the form of oedema with
or without respiratory deterioration in the higher-volume feeds
group (27%) than in the standard-volume feeds group (14%), this
difference was not statistically signiﬁcant (Kuschel 2000).
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A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Although data from one small unblinded trial indicate that high-
volume enteral feeds increase the rate of weight gain without in-
creasing risk of feed intolerance or necrotising enterocolitis (NEC),
the quality of evidence is low to very low. Hence, available evi-
dence is insufﬁcient to support or refute high-volume enteral feeds
in preterm or low birth weight (LBW) infants.
Implications for research
A large randomised controlled trial (RCT) is needed to assess
whether high-volume versus standard-volume enteral feeds im-
prove important clinical outcomes for preterm or LBW infants.
Such a trial should assess weight and linear and head growth, post-
discharge growth, neurodevelopmental outcomes, and risk of po-
tential complications of high-volume enteral feeds. A trial of this
intervention may be regarded as a research priority, especially in
settings where a multi-nutrient fortiﬁer is less likely to be used to
supplement nutrient intake.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Thomas 2012
Methods RCT
Participants 64 newborn VLBW infants were enrolled when they achieved 200 mL/kg/d enteral
feeds. Both appropriate-for-gestational-age and small-for-gestational-age infants were
included. Only birth weight (not gestational age) criteria were used for enrolment
Interventions Intervention arm (N = 32): *Feeds were graded up by 20 mL/kg/d up to 300 mL/kg/d
Control arm (N = 32): *Feeds were continued at 200 mL/kg/d
Babies in both intervention and control arms were given expressed breast milk along with
individual micronutrient supplements for calcium, iron, and vitamins. Multi-nutrient
milk fortiﬁers, which supplement calories and proteins, were not used. Feeds were given
by nasogastric tube at 2- to 3-hourly intervals
Outcomes Primary outcome: weight gain (g/kg/d) from enrolment until baby reached weight of
1700 grams
Secondary outcomes: feed intolerance, tachypnoea, NEC (stage 2a or greater), bacter-
aemia or fungaemia, biochemical abnormalities
Notes Setting: Neonatology Unit, Christian Medical College Hospital, Vellore (a tertiary care
teaching hospital in South India)
*Twelve infants in the high-volume group did not achieve the targeted 300 mL/kg/d
(although all achieved feed volumes > 250 mL/kg/d), and 6 infants in the standard-
volume group received higher volumes than targeted (up to 215 mL/kg/d), but analyses
were done by “intention-to-treat”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Personal communication: ’computer-generated random se-
quence’
Allocation concealment (selection bias) Low risk Personal communication: ’sealed opaque envelopes opened by
the principal investigator only at the time of allocation’
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Unblinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Unblinded
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Thomas 2012 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Three (of 64) randomised infants were removed from the study
by parents, did not complete the intervention, and were not
included in analyses
Selective reporting (reporting bias) Low risk Personal communication: ’all proposed outcomes reported’
Other bias Low risk Nil
NEC: necrotising enterocolitis.
RCT: randomised controlled trial.
VLBW: very low birth weight.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Kuschel 2000 This study compared 2 enteral feed volumes: 150 mL/kg/d and 200 mL/kg/d (both “standard” volumes)
Lewis 1984 This is a retrospective study of 87 low birth weight infants fed 250 mL/kg/d; not a randomised controlled trial
Valman 1974 This is a cohort study comparing 2 feed volumes: 180 mL/kg/d and 230 mL/kg/d; not a randomised controlled trial
Zecca 2014 This study compared 2 enteral feed volumes: 170 mL/kg/d and 200 mL/kg/d (both “standard” volumes); rate of
advancement of feeds was different between groups (in 170-mL groups, feeds were started at 60 mL/kg/d on day 1
and were advanced to full feeds on day 9; in 200-mL group, feeds were started at 100 mL/kg/d on day 1 and were
advanced to full feeds on day 4)
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D A T A A N D A N A L Y S E S
Comparison 1. High-volume vs standard-volume feeds
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Weight gain (g/kg/d) 1 61 Mean Difference (IV, Fixed, 95% CI) 6.20 [2.71, 9.69]
2 Feed intolerance 1 61 Risk Ratio (M-H, Fixed, 95% CI) 1.81 [0.89, 3.67]
3 Necrotising enterocolitis 1 61 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.07, 15.78]
Analysis 1.1. Comparison 1 High-volume vs standard-volume feeds, Outcome 1 Weight gain (g/kg/d).
Review: High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants
Comparison: 1 High-volume vs standard-volume feeds
Outcome: 1 Weight gain (g/kg/d)
Study or subgroup High volume feeds
Standard
volume
feeds
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Thomas 2012 30 24.9 (7.6) 31 18.7 (6.2) 100.0 % 6.20 [ 2.71, 9.69 ]
Total (95% CI) 30 31 100.0 % 6.20 [ 2.71, 9.69 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.48 (P = 0.00049)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours standard volume Favours high volume
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Analysis 1.2. Comparison 1 High-volume vs standard-volume feeds, Outcome 2 Feed intolerance.
Review: High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants
Comparison: 1 High-volume vs standard-volume feeds
Outcome: 2 Feed intolerance
Study or subgroup High volume feeds
Standard
volume
feeds Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thomas 2012 14/30 8/31 100.0 % 1.81 [ 0.89, 3.67 ]
Total (95% CI) 30 31 100.0 % 1.81 [ 0.89, 3.67 ]
Total events: 14 (High volume feeds), 8 (Standard volume feeds)
Heterogeneity: not applicable
Test for overall effect: Z = 1.64 (P = 0.10)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours high volume Favours standard volume
Analysis 1.3. Comparison 1 High-volume vs standard-volume feeds, Outcome 3 Necrotising enterocolitis.
Review: High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants
Comparison: 1 High-volume vs standard-volume feeds
Outcome: 3 Necrotising enterocolitis
Study or subgroup High volume feeds
Standard
volume
feeds Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thomas 2012 1/30 1/31 100.0 % 1.03 [ 0.07, 15.78 ]
Total (95% CI) 30 31 100.0 % 1.03 [ 0.07, 15.78 ]
Total events: 1 (High volume feeds), 1 (Standard volume feeds)
Heterogeneity: not applicable
Test for overall effect: Z = 0.02 (P = 0.98)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours high volume Favours standard volume
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A D D I T I O N A L T A B L E S
Table 1. Typical energy and protein content of human milk or formula
per 100 mL Expressed breast milk
(EBM)
EBM
+ Fortiﬁer
Term formula Preterm formula
Energy (kCal) 67 74 to 80 67 80
Protein (g) 1.2 to 1.7 2.0 to 2.5 1.5 2.4
A P P E N D I C E S
Appendix 1. Search strategy
De-duplicated search results from: PubMed, Embase, CINAHL, Cochrane Library (Search date: No limit - November 14, 2016)
Search terms: breast milk OR diet supplementation OR ((fortif* OR supplemented OR supplementation) near ((human OR breast
OR expressed) NEAR milk))
Plus the following database-speciﬁc terms:
PubMed: ((infant, newborn[MeSH] OR newborn OR neonate OR neonatal OR premature OR low birth weight OR VLBW OR
LBW or infan* or neonat*) AND (randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo
[tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals [mh] NOT humans [mh]))
Embase: (infant, newborn or newborn or neonate or neonatal or premature or very low birth weight or low birth weight or VLBW or
LBW or Newborn or infan* or neonat*) AND (human not animal) AND (randomized controlled trial or controlled clinical trial or
randomized or placebo or clinical trials as topic or randomly or trial or clinical trial)
CINAHL: (infant, newborn OR newborn OR neonate OR neonatal OR premature OR low birth weight OR VLBW OR LBW or
Newborn or infan* or neonat*) AND (randomized controlled trial OR controlled clinical trial OR randomized OR placebo OR clinical
trials as topic OR randomly OR trial OR PT clinical trial)
Cochrane Library: (infant or newborn or neonate or neonatal or premature or very low birth weight or low birth weight or VLBW or
LBW)
Appendix 2. Risk of bias
• Random sequence generation: We categorised the method used to generate the allocation sequence as:
◦ low risk of bias: Any random process (e.g. random number table; computer random number generator; coin tossing;
shufﬂing of cards or envelopes; throwing of dice; drawing of lots; minimisation) (may be implemented without a random element;
this is considered equivalent to being random);
◦ high risk of bias: any non-random process (e.g. sequence generated by odd or even date of birth; date (or day) of admission;
sequence generated by hospital or clinic record number; allocation by judgement of the clinician; allocation by preference of the
participant; allocation based on results of a laboratory test or series of tests; allocation based on availability of the intervention); or
◦ unclear risk of bias: insufﬁcient information about the sequence generation process to permit judgement.
• Allocation concealment: We categorised the method used to conceal the allocation sequence as:
◦ low risk of bias: randomisation method described that would not allow investigator/participant to know or inﬂuence the
intervention group before eligible participants entered the study (i.e. central allocation, including telephone, Web-based, and
pharmacy-controlled randomisation; sequentially numbered drug containers of identical appearance; sequentially numbered, opaque,
sealed envelopes);
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◦ high risk of bias: open random allocation schedule (i.e. list of random numbers); assignment envelopes used without
appropriate safeguards (e.g. if envelopes were unsealed or non-opaque, or were not sequentially numbered); alternation or rotation;
date of birth; case record number; any other explicitly unconcealed procedure; or
◦ unclear risk of bias: randomisation stated but no information provided on method used.
• Blinding of participants and personnel: We assessed blinding of participants, clinicians and caregivers, and outcome assessors
separately for different outcomes and categorised the methods used as:
◦ low risk of bias: no blinding or incomplete blinding, but review authors judged that the outcome was not likely to be
inﬂuenced by lack of blinding; blinding of participants and key study personnel ensured, and unlikely that blinding could have been
broken;
◦ high risk of bias: no blinding or incomplete blinding, and the outcome was likely to be inﬂuenced by lack of blinding;
blinding of key study participants and personnel attempted, but likely that blinding could have been broken, and the outcome was
likely to be inﬂuenced by lack of blinding; or
◦ unclear risk of bias: insufﬁcient information to permit judgement.
• Incomplete outcome data: We described the completeness of data including attrition and exclusions from analysis for each
outcome and reasons for attrition or exclusion when reported. We assessed whether missing data were balanced across groups or were
related to outcomes. We categorised completeness as:
◦ low risk of bias: no missing outcome data; reasons for missing outcome data unlikely to be related to true outcome (for
survival data, censoring unlikely to introduce bias); missing outcome data balanced in numbers across intervention groups, with
similar reasons for missing data across groups; for dichotomous outcome data, proportion of missing outcomes compared with
observed event risk not enough to have a clinically relevant impact on the intervention effect estimate; for continuous outcome data,
plausible effect size (difference in means or standardised difference in means) among missing outcomes not sufﬁcient to have a
clinically relevant impact on observed effect size; missing data imputed by appropriate methods;
◦ high risk of bias: reason for missing outcome data likely to be related to true outcome, with imbalance in numbers or
reasons for missing data across intervention groups; for dichotomous outcome data, proportion of missing outcomes compared with
observed event risk enough to induce clinically relevant bias in intervention effect estimate; for continuous outcome data, plausible
effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias
in observed effect ’as-treated’ analysis done with substantial departure of the intervention received from that assigned at
randomisation; potentially inappropriate application of simple imputation; or
◦ unclear risk of bias: insufﬁcient information to permit judgement.
• Selective reporting: We assessed reporting bias due to selective outcome reporting as:
◦ low risk of bias: study protocol available, and all of the study’s prespeciﬁed (primary and secondary) outcomes of interest in
the review had been reported in the prespeciﬁed way; study protocol not available, but it was clear that published reports included all
expected outcomes, including those that were prespeciﬁed;
◦ high risk of bias: not all of the study’s prespeciﬁed primary outcomes reported; one or more primary outcomes reported by
measurements, analysis methods, or subsets of data (i.e. subscales) that had not been prespeciﬁed; one or more reported primary
outcomes not prespeciﬁed (unless clear justiﬁcation for their reporting is provided, such as an unexpected adverse effect); one or more
outcomes of interest in the review reported incompletely, so they could not be entered into a meta-analysis; study report failed to
include results for a key outcome that would be expected to be reported for such a study; or
◦ unclear risk of bias: insufﬁcient information to permit judgement.
• Other bias: We analysed bias due to problems not covered elsewhere in the table as:
◦ low risk of bias: study appears to be free of other sources of bias;
◦ high risk of bias: study had a potential source of bias related to the speciﬁc study design used; stopped early because a data-
dependent study design was used; stopped early as the result of a data-dependent process (including a formal stopping rule); had
extreme baseline imbalance; was claimed to be fraudulent; had some other problem; or
◦ unclear risk of bias: insufﬁcient information to assess whether an important risk of bias existed; insufﬁcient rationale or
evidence to suggest that an identiﬁed problem would introduce bias.
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Appendix 3. GRADE assessment of quality of evidence
GRADE considers evidence from randomised controlled trials as high quality that may be downgraded on the basis of consideration
of any of ﬁve areas.
• Design (risk of bias).
• Consistency across studies.
• Directness of evidence.
• Precision of estimates.
• Presence of publication bias.
The GRADE approach results in assessment of the quality of a body of evidence according to four grades (Schünemann 2013).
• High: We are very conﬁdent that the true effect lies close to the estimate of effect.
• Moderate: We are moderately conﬁdent in the effect estimate: The true effect is likely to be close to the estimate of effect but
may be substantially different.
• Low: Our conﬁdence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect.
• Very low: We have very little conﬁdence in the effect estimate: The true effect is likely to be substantially different from the
estimate of effect.
C O N T R I B U T I O N S O F A U T H O R S
All review authors developed the protocol. TA andWM screened search outputs, assessed study eligibility, and extracted and synthesised
data. TA and VA assessed risk of bias across key domains and undertook GRADE assessment with WM. All review authors revised the
ﬁnal review.
D E C L A R A T I O N S O F I N T E R E S T
Dr. Thomas was the principal investigator in the only study included in the review (Thomas 2012).
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